Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Amish Raval Added: 1 month ago
ACC 2025 - Principal results from autologous cell therapy in patients with heart failure with reduced ejection fraction (HFrEF) show favourable safety outcomes, however, the study did not meet its primary efficacy outcome using 6 minute walking rests as 3rd F-S tier.Dr Amish Raval (UW Health University Hospital Interventional Cardiology Clinic, WI, US) joins us onsite at ACC to discuss the… View more
Research Area(s) / Expertise:

Chronic Kidney Disease

Job title: Laboratory of Nephrology, Bambino Gesù Children's Hospital, Rome, Italy
Dr. Marina Vivarelli is a renowned pediatric nephrologist with extensive expertise in immune-mediated renal diseases. Initially trained as a pediatrician, she developed a strong focus on pediatric immunology, working in the labs of leading experts like Fabrizio De Benedetti in Pavia and Raif Geha at Children's Hospital Boston. Since 2006, Dr. Vivarelli has been part of the Division of Nephrology… View more
Research Area(s) / Expertise: Job title: MD
Dr Tschöpe is Professor of Medicine and Cardiology and the Vice Director of the Department of Cardiology, Charité, Campus Virchow Klinikum, Berlin, guiding the cardiomyopathy programme. His main research interests are the potential of cell therapies to cure heart failure and the role of the immune system in heart failure. View more
Research Area(s) / Expertise: Job title: MD Washington University School of Medicine, St Louis, MO, US
Dr Mann is the Lewin Chair and Professor of Medicine, Cell Biology and Physiology, at the Washington University School of Medicine, and Cardiologist-in-chief at Barnes Jewish Hospital in St Louis, Missouri, US. His research focus has been the molecular and cellular basis of heart failure, with particular emphasis on the role of innate immunity in disease progression and recovery of the failing… View more
Job title: Associate Professor and Consultant in Uro-Oncology
Dr Mark Linch is an Associate Professor at University College London (UCL) Cancer Institute, where he leads the Urological Cancer Biology Group, and Honorary Consultant Medical Oncologist. Dr Linch trained in medical oncology at the Royal Marsden Hospital (RMH), London. In 2012 he was awarded a PhD in Cancer Cell Biology from UCL and the Cancer Research UK London Research Institute (LRI), now… View more